June 29, 2022
Life Sciences
  • An expert advisory vaccine panel for the Food and Drug Administration (FDA) recommended updated COVID-19 vaccines specifically designed to combat the omicron variant. Nineteen members of the Vaccines and Related Biological Products Advisory Committee voted in favor of the endorsement and two voted against it. Several members of the vaccine panel reasoned that the likely benefits of an omicron-specific vaccine — possibly a bivalent shot — outweighed the possible risks. (Articles here, here, here, here, here, here, and here)